Prostate Cancer Ontology
Center for Systems Biology, Sichuan University West China Hospital, Sichuan China
跳过导航链接。
折叠 前列腺癌前列腺癌
展开 前列腺癌流行病学前列腺癌流行病学
展开 前列腺癌的诊断前列腺癌的诊断
折叠 前列腺癌的治疗前列腺癌的治疗
展开 延期治疗延期治疗
展开 外科手术外科手术
展开 放射疗法放射疗法
展开 冷冻疗法冷冻疗法
展开 激素疗法激素疗法
展开 化疗化疗
展开 去势抵抗性前列腺癌(CRPC)去势抵抗性前列腺癌(CRPC)
展开 转移性前列腺癌转移性前列腺癌
折叠 其他治疗方式其他治疗方式
折叠 老年男性前列腺癌的治疗老年男性前列腺癌的治疗
展开 局部前列腺癌除手术和放疗以外的其他初级治疗选择局部前列腺癌除手术和放疗以外的其他初级治疗选择
展开 局部前列腺癌患者的治疗后生活质量局部前列腺癌患者的治疗后生活质量
展开 根治性目的治疗后仅限PSA复发的治疗根治性目的治疗后仅限PSA复发的治疗
预期寿命、共病与健康状况评估
Preferred Name Evaluation of life expectancy, comorbidity and health status
Definition In localised disease, > 10 years life expectancy is considered mandatory for any benefit from local treatment. Life expectancy varies within each age group. This can be explained by comorbidity, which is more important than age in predicting death in localised PCa. Besides comorbidities, dependence in daily activities, malnutrition and cognitive impairment are associated with worse survival.
Synonyms & Abbreviations Evaluation of life expectancy, comorbidity and health status
ReferenceCode NA
ReferenceURL NA
PMID NA
Copyright (C) 2022 Institutes for Systems Genetics, Sichuan University West China Hospital. All Rights Reserved.